Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
  1. 4 Grant or award Director acquired 2,021 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale Matsuda Masaru sold 1,657 shares at $30.23 ($50,091)
  4. 4 Planned sale Director sold 10,000 shares at $30.21 ($302,133)
  5. 4 Open-market sale Director sold 25,272 shares at $30.78 ($777,956)
  6. 4 Planned sale Watanabe Todd sold 50,000 shares at an average $30.35 ($1,517,405)
  7. 4 Planned sale Matsuda Masaru sold 2,550 shares at an average $28.29 ($72,135)
  8. 4 Open-market sale Director sold 16,532 shares at $27.55 ($455,442)
  9. 4 Planned sale Director sold 40,504 shares at an average $23.20 ($939,494)
  10. 4 Gift Director gave 4,312 shares (gift)
  11. 4 Open-market sale Edwards Larry Todd sold 29,131 shares at $25.16 ($732,927)
  12. 4 Planned sale Burnett Patrick sold 17,250 shares at $24.18 ($417,145)
  13. 4 Planned sale Burnett Patrick sold 6,486 shares at an average $24.12 ($156,449)
  14. 4 Planned sale Director sold 10,000 shares at $25.27 ($252,669)
  15. 4 Planned sale SVP Chief Financial Officer sold 88 shares at $24.72 ($2,175)
  16. 4 Planned sale Watanabe Todd sold 11,547 shares at an average $24.72 ($285,399)
  17. 4 Planned sale Matsuda Masaru sold 7,208 shares at an average $24.72 ($178,156)
  18. 4 Planned sale Watanabe Todd sold 40,000 shares at $25.03 ($1,001,032)
  19. 4 Planned sale Edwards Larry Todd sold 4,504 shares at an average $20.04 ($90,263)
  20. 4 Planned sale Watanabe Todd sold 45,000 shares at an average $19.66 ($884,649)

Page 4 of 23 · 452 filings